<DOC>
	<DOCNO>NCT00345332</DOCNO>
	<brief_summary>The purpose study determine effective Botox reduce amount urine leak dose Botox effective safe urinary urge incontinence .</brief_summary>
	<brief_title>A Multi-Center Trial Botox Severe Urge Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Female subject 2190 year age subject urinary incontinence 3 day blader diary subject severe incontinence urine dipstick urine colture negative urinary tract infection cystometrogram without stress urinary leakage must fail least one anticholinergic medication negative urine pregnancy test day administration study medication history carcinoma bladder presence foreign body bladder , cyctitis correctable etiology UUI gross fecal incontinence know allergy sulfa ciprofloxacin lidocaine medical condition may put subject increase risk exposure Botox females pregnant , breastfeeding , plan pregnancy study childbearing potential know allergy component study medication prior document resistance Botox evidence recent alcohol drug abuse concurrent participation another investigational drug device study within 30 day</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>